[HTML][HTML] Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms

K Huang, X Luo, B Liao, G Li, J Feng - Cardiovascular Diabetology, 2023 - Springer
Among the complications of diabetes, cardiovascular events and cardiac insufficiency are
considered two of the most important causes of death. Experimental and clinical evidence …

[HTML][HTML] Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment

P Xiong, F Zhang, F Liu, J Zhao, X Huang, D Luo… - Biomedicine & …, 2023 - Elsevier
The public health issue of glucolipid metabolic disorders (GLMD) has grown significantly,
posing a grave threat to human wellness. Its prevalence is rising yearly and tends to affect …

NLRP3 inflammasome-targeting nanomicelles for preventing ischemia–reperfusion-induced inflammatory injury

R Prakash, A Vyawahare, R Sakla, N Kumari… - ACS …, 2023 - ACS Publications
Ischemia–reperfusion (I/R) injury is a disease process that affects several vital organs. There
is widespread agreement that the NLRP3 inflammasome pathway plays a crucial role in the …

Spatiotemporal On–Off Immunomodulatory Hydrogel Targeting NLRP3 Inflammasome for the Treatment of Biofilm‐Infected Diabetic Wounds

J Zhou, J Mei, Q Liu, D Xu, X Wang… - Advanced Functional …, 2023 - Wiley Online Library
Biofilm‐infected diabetic wounds (BIDWs) with hyperglycemia and bacterial colonization are
characterized by disordered inflammation and abnormal activation of NLRP3 …

[HTML][HTML] Metformin protects against retinal ischemia/reperfusion injury through AMPK-mediated mitochondrial fusion

K Zhang, T Wang, GF Sun, JX Xiao, LP Jiang… - Free Radical Biology …, 2023 - Elsevier
Retinal ischemia/reperfusion (I/R) injury is a common pathological process responsible for
cellular damage in glaucoma, diabetic retinopathy and hypertensive retinopathy. Metformin …

[HTML][HTML] SGLT-2 inhibitors and the inflammasome: what's next in the 21st century?

D Kounatidis, N Vallianou, A Evangelopoulos… - Nutrients, 2023 - mdpi.com
The nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome in the kidney
and the heart is increasingly being suggested to play a key role in mediating inflammation …

[HTML][HTML] Vitamin B12 alleviates myocardial ischemia/reperfusion injury via the SIRT3/AMPK signaling pathway

Y Qin, Y Shi, Q Yu, S Yang, Y Wang, X Dai, G Li… - Biomedicine & …, 2023 - Elsevier
Aim To examine the protective effect of vitamin B12 against myocardial ischemia/reperfusion
(I/R) injury and elucidate its underlying mechanism of action. Methods Mice were subjected …

[HTML][HTML] Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis

L Wang, J Liu, Z Wang, X Qian, Y Zhao, Q Wang… - Biomedicine & …, 2023 - Elsevier
The current study intended to delve into the mechanisms of dexmedetomidine (Dex) in
regulating myocardial pyroptosis against myocardial ischemia/reperfusion injury (MIRI). The …

[HTML][HTML] Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling

Y Wang, R Zhao, C Wu, X Liang, L He… - Frontiers in …, 2023 - frontiersin.org
Myocardial remodeling refers to structural and functional disorders of the heart caused by
molecular biological changes in the cardiac myocytes in response to neurological and …

Broadening horizons: The role of ferroptosis in myocardial ischemia–reperfusion injury

K Zhao, X Chen, Y Bian, Z Zhou, X Wei… - … Archives of Pharmacology, 2023 - Springer
Ferroptosis is a novel type of regulated cell death (RCD) discovered in recent years, where
abnormal intracellular iron accumulation leads to the onset of lipid peroxidation, which …